Brochure

Bifiasthm, prevent asthmatic crises and support the immune system

Bifiasthm, prevent asthmatic crises and support the immune system

Bifiasthm is a probiotic product proposed for children with asthma, in order to prevent asthmatic crises and support the balance of the immune system reactivitity. Bifiasthm is based on two strains with immunomodulatory activity targeted for allergic asthmatic subjects. A placebo-controlled clinical trial pending publication in 2020 and involving 500 asthmatic children showed that Bifiasthm was able to reduce significantly the episodes of asthma.